EPIRUS Biopharmaceuticals, Inc (EPRS) - NASDAQ
  • timothy russell | Send Message 27 Jul

    $EPRS vertical
    Reply
      • timtrading | Send Message 7 Jul

        top health care stocks today $EPRS,$AXN,$EYES,$TLOG,$BSPM,$PTX,$AVXL,$BMRN,$ACHN,$FOLD http://bit.ly/29sCXen
        Reply
          • timothy russell | Send Message 7 Jul

            $EPRS nice move so far
            Reply (1)
            • mr.investor | Send Message 7 Jul
              : Why the bump? Their last 10-k said they are about to file for BK.
              • mr.investor | Send Message 2 Jul

                $EPRS - any hope? lol
                Reply
                  • Colin Macleod | Send Message 23 Jun

                    $EPRS - Epirus Biopharmaceuticals Inc - Independent Analysis Video http://tinyurl.com/hkkxg2o
                    Reply
                      • timtrading | Send Message 22 Jun

                        top stocks today $KBSF,$SPU,$EPRS,$NYMX,$ASPN,$CNXR,$APRI,$CETX,$INVT,$DELT http://tinyurl.com/zkz6h4g
                        Reply
                          • Neil_P | Send Message 22 Jun

                            Sold $EPRS 0.485 --> 0.665 37% profit
                            Reply
                              • Neil_P | Send Message 22 Jun

                                $EPRS BOOM BOOM BOMBASTIC ...!!!!!
                                Reply
                                  • Neil_P | Send Message 22 Jun

                                    Bought $EPRS @ 0.485
                                    Reply
                                      • wilkinson99 | Send Message 22 Jun

                                        Top % Gainers: $KBSF 121% (Halted) $SPU 58%, $NYMX 31%, $CETX 25%, $INVT 24%, $SGY 23%, $ASPN 21%, $DELT $REXX $NROM $PSTI $SCTY $EPRS $RXII
                                        Reply
                                          Company Description
                                          EPIRUS Biopharmaceuticals, Inc. engages in the development and commercialization of biosimilar monoclonal antibodies. It develops a monoclonal antibody BOW015 which carries a brand name Remicade. The company operates its business through one operating segment: the development and... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States